Speaker illustration

Professor Guillaume Pare

McMaster University, Hamilton (Canada)

Member of:

European Society of Cardiology

Guillaume Paré is Director of the Clinical Research Laboratory and Biobank (CRLB) – Genetic and Molecular Epidemiology Laboratory (GMEL). He is also Deputy Director of the Thrombosis and Atherosclerosis Research Institute (TaARI), a Professor of Pathology and Molecular Medicine, and a University Scholar at McMaster University. A practicing clinician-scientist, Dr. Paré completed a Master’s in Human Genetics at McGill University under the supervision of Thomas Hudson. He further trained in genetic epidemiology with Paul Ridker at Harvard Medical School. His clinical interests are centered on lipoprotein disorders, obesity and cardiovascular disease prevention, with research interests in cardiovascular genetics, biomarker development and pharmacogenomics. Dr. Paré’s research combines high-throughput biomarker screens with genetics, bioinformatics and epidemiology to identify novel cardio-metabolic biomarkers. He has published over 340 original contributions in peer-reviewed journals. Th

Genetics and epigenetics: impact on global cardiovascular disease

Event: ESC Congress 2025

Topic: European Society of Cardiology

Session: 25 years of the Prospective Urban Rural Epidemiology (PURE) study

Thumbnail